查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球气道管理设备市场 - 2023-2030
市场调查报告书
商品编码
1352117

全球气道管理设备市场 - 2023-2030

Global Airway Management Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

在各种情况下，从简单的窒息到复杂的气道阻塞，个人可能需要气道管理。气道阻塞最常见的原因是舌头或异物阻塞呼吸道。它也可能是气道损伤、血液和分泌物（例如唾液和黏液）增加或气道发炎的结果。

此外，气道管理设备市场受到多种因素的推动，例如呼吸系统疾病盛行率的上升、手术数量的增加、麻醉的使用、医疗保健支出的增加、医疗保健基础设施的进步以及对医疗设备的高需求。扩大护理服务都有利于气道管理设备市场。

动力学

呼吸道疾病盛行率上升

呼吸道疾病盛行率的增加是预测期内帮助市场成长的关键驱动因素之一。由于呼吸系统疾病的增加，气道管理设备的使用经常被迅速使用，这确实会增加市场的成长。例如，根据疾病管制与预防中心的数据，慢性阻塞性肺病估计影响 2 亿人，每年有 320 万人死亡，使其成为全球第三大死因。

气喘是最常见的非传染性疾病之一，影响全球 2.62 亿人。预计 2022 年将有近 220 万例新发肺癌病例和 180 万人死亡，肺癌占全球癌症死亡人数的四分之一。下呼吸道感染或肺炎是重要的死亡原因，每年造成超过 240 万人死亡，主要发生在低收入和中等收入国家 (LMIC)。 COVID-19 显着增加了全球肺炎死亡人数。

气道管理技术先进设备开发的兴起

开发技术先进的气道管理设备的成长是帮助气道管理设备市场在预测期内成长的关键驱动力之一。

例如，2022 年 1 月，ICU Medical Inc. 完成了从 Smiths Group PLC 收购 Smiths Medical，增加全球气道管理设备、重要护理产品、门诊输液设备等产品组合，从而改善患者治疗体验并改善整体成果。

缺乏报销政策

由于医疗保险计划薄弱，发展中国家对昂贵的气道管理设备的采用率较低。根据世界银行集团的数据，每人每年平均医疗保健支出为 80 美元，这使得人们更容易患慢性病和 COVID-19 流行病。

到 2030 年，54 个最贫困国家的全民健保资金缺口预计将达到 1,760 亿美元。视讯喉镜等医疗设备和复杂手术方法的有限采用限制了气道管理设备的市场份额。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按类型分類的片段
  • 按年龄摘录
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 呼吸道疾病盛行率上升
      • 气道管理技术先进设备开发的兴起
    • 限制
      • 缺乏报销政策
    • 机会
      • 发展中国家不断成长的成长潜力
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情况
    • Covid-19 后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按类型

  • 喉镜
  • 声门下气道管理装置
  • 声门上气道管理装置
  • 復苏器
  • 环甲膜切开术套件
  • 其他

第 8 章：依年龄

  • 儿科/新生儿
  • 成年人

第 9 章：最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
      • 亚太其他地区
  • 中东和非洲
    • 关键地区特定动态

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Medtronic
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Boston Scientific Corporation
  • Olympus Corporation
  • ICU Medical, Inc
  • ConvaTec Group Plc
  • KARL STORZ
  • Teleflex Incorporated
  • Ambu A/S
  • Verathon Inc
  • SourceMark

第 13 章：附录

简介目录
Product Code: MD6868

Overview

Airway management may be required for individuals in a variety of circumstances, ranging from simple choking to complicated airway obstruction. Airway obstruction most commonly occurs as a result of the tongue or foreign bodies blocking the airway. It can also be the result of injury to the airway, increased presence of blood and secretions (e.g., saliva and mucus), or inflammation of the airway.

Futhermore, the airway management devices market is driven by various factors like rising prevalence of respiratory diseases, and as the number of surgeries increases, so does the use of anaesthesia, the increase in healthcare spending, advancements in healthcare infrastructure, and a high demand for expanded care delivery all benefit the airway management device market.

Dynamics

Rise in Prevalence of Respiratory Diseases

Increase prevalence of respiratory disease is one the key driver that helps the market to grow during forecast period. Since rise in respiratory diseases the use of airway managmenet devices are often used rapdily which indeed will increase the market growth. For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 million people, with 3.2 million dying each year, making it the third-leading cause of mortality globally.

Asthma is one of the most common noncommunicable illnesses, impacting 262 million people worldwide.With almost 2.2 million new instances of lung cancer expected in 2022 and 1.80 million fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 million fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.

Rise in Developing Technologically Advanced Devices in Airway Management

Rise in developing technologically advanced devices in airway management is one of the key driver that helps the airway management devices market to grow during the forecast period.

For instance, in January 2022, ICU Medical Inc., completed the acquisition of Smiths Medical from Smiths Group PLC, to increase the product portfolio globally in devices for airway management, vital care products, ambulatory infusion devices, and others to enhance the patient treatment experience and improve overall outcomes.

Lack of Reimbursement Policies

Due to poor healthcare insurance programmes, developing nations have low adoption rates for pricey airway management devices. According to the World Bank Group, the average yearly healthcare expenditure is $80 per person, making the population more prone to chronic sickness and COVID-19 epidemics.

The financial shortfall for universal health care is anticipated to reach $176 billion by 2030 among the 54 poorest countries. The limited adoption of medical equipment such as video laryngoscopes and sophisticated surgical methods restricts the market share of airway management devices.

Segment Analysis

The global airway management devices is segmented based on type, age, end user and region.

The Laryngoscopes From Type Segment Accounted for Approximately 42.5 % of the Airway Management Devices Share

The laryngoscopes from type segment with around 42.5% is expected to dominate during the forecast period. Laryngoscopy is a visual examination using a throat scope to view the larynx, which contains vocal cords. It helps diagnose ear or throat pain, airway blockages, throat narrowing, and swallowing difficulties.

For instance, in April 2022 OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, launched new laryngoscope reference designs that include a range of OMNIVISION products that help improve patient care by providing crisp, clear images for single-use video laryngoscopes. Visualization makes insertion of the endotracheal tube easier and faster and avoids failures in difficult airways, significantly reducing the chances of complications and even death.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising R&D and introduction of new technologies in devices of airway management by key players to help aid in patient treatment is likely to drive the North America market growth. Moreover, increasing collaborations among manufacturing players and rising approvals of new airway devices with extensive presence across the region also drive the this region in future.

For instance, on June 21, 2023 Teleflex Incorporated a leading global provider of medical technologies, announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. As the exclusive U.S. distributor of the Insighters Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.

Competitive Landscape

The major global players in the airway management devices market include: Medtronic , Boston Scientific Corporation , Olympus Corporation, ICU Medical, Inc, ConvaTec Group Plc, KARL STORZ, Teleflex Incorporated , Ambu A/S , Verathon Inc, SourceMark and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic has increased the number of patients admitted to emergency departments and intensive care units. Patients suffering from severe infections typically have respiratory failure or low oxygen saturation, necessitating the use of positive air pressure devices such as ventilators. As a result, demand for airway control devices, particularly single-use devices, is increasing.

As non-invasive methods carry the potential of virus particle aerosolization, the number of patients requiring intubation via invasive airway management procedures has grown. Healthcare practitioners that provide airway management treatment to COVID-19 patients and other patients in healthcare institutions are putting themselves at danger, which has boosted the need for single-use devices.

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global airway management devices, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global airway management devices growth over the forecast period.

By Type

  • Laryngoscopes
  • Infraglottic Airway Management Devices
  • Supraglottic Airway Management Devices
  • Resuscitators
  • Cricothyrotomy Kits
  • Others

By Age

  • Pediatrics/Neonates
  • Adults

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In Jan 2022 Qure.ai, a health tech firm, received FDA approval for an artificial intelligence (AI) algorithm, qXR-BT, that helps doctors in assessing Breathing Tube (BT) placements. The algorithm helps clinicians locate the BT location and automate measurements for intubated patients using chest X-rays.
  • In May 2021, Medtronic introduced the SonarMed airway monitoring system, acoustic technology for real-time monitoring of endotracheal tube (ETT) obstruction and position in neonates and infants. This innovative device helps clinicians make informed decisions for life-saving care.
  • In May 2021, Olympus Corporation announced the FDA clearance of its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures.

Why Purchase the Report?

  • To visualize the global airway management devices market segmentation based on type, age, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global airway management devices market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global airway management devices market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Age
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Prevalence of Respiratory Diseases
      • 4.1.1.2. Rise in Developing Technologically Advanced Devices in Airway Management
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Reimbursement Policies
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Growth Potential in Developing Countries
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Laryngoscopes *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Infraglottic Airway Management Devices
  • 7.4. Supraglottic Airway Management Devices
  • 7.5. Resuscitators
  • 7.6. Cricothyrotomy Kits
  • 7.7. Other

8. By Age

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 8.1.2. Market Attractiveness Index, By Age
  • 8.2. Pediatrics/Neonates*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Adults

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Boston Scientific Corporation
  • 12.3. Olympus Corporation
  • 12.4. ICU Medical, Inc
  • 12.5. ConvaTec Group Plc
  • 12.6. KARL STORZ
  • 12.7. Teleflex Incorporated
  • 12.8. Ambu A/S
  • 12.9. Verathon Inc
  • 12.10. SourceMark

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us